Home
November 2008 December 2008 January 2009
Su Mo Tu We Th Fr Sa
Week 49 1 2 3 4 5 6
Week 50 7 8 9 10 11 12 13
Week 51 14 15 16 17 18 19 20
Week 52 21 22 23 24 25 26 27
Week 1 28 29 30 31

Long-Term Outcome Of Transcatheter Embolization Of Renal Angiomyolipomas Due To Tuberous Sclerosis Complex Show Comments PDF Print E-mail
  
Friday, 23 December 2005
BERKELEY, CA (UroToday.com) - Large (>4 cm) or clinically symptomatic angiomyolipomas (AML) are common in patients with tuberous sclerosis complex (TSC).

BERKELEY, CA (UroToday.com) - Large (>4 cm) or clinically symptomatic angiomyolipomas (AML) are common in patients with tuberous sclerosis complex (TSC). These types of tumors should be primarily managed with transcatheter embolization. In this study of 16 patients, treated for 27 tumors, there were no intraoperative complications, no renal failures or hemorrhage developing during three to nine years of followup. The postembolization syndrome required hospitalization for between two to five days and consisted of pain, nausea and vomiting, or fever. The fever typically peaked at 48 hours after the embolization procedure. However, these symptoms were adequately managed with intravenous fluids, analgesics, antipyretics, and anti-emetics. Transcatheter embolization for large or symptomatic AML due to TSC is minimally invasive, preserves renal function, and can be performed multiple times. There rarely remains an indication to address these lesions by extirpative renal surgery.

J Urol 174: 1764-1766, 2005

Written by Elspeth M. McDougall, MD, a Contributing Editor with UroToday.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev   Next >